Radoslav Raychev, Neuronics Medical AI | ACTAI Global Asia Pacific 2025

In this episode of theCUBE Studios, Radoslav Raychev, co-founder and CEO of Neuronics Medical, discusses the advancements in Medical AI and its role in stroke detection. Featured during the ACTAI Global Asia Pacific 2025 event, Raychev shares insights into why timely stroke diagnosis is crucial and how Neuronics Medical aims to revolutionize stroke detection through innovative AI technologies. The conversation highlights the enormous societal impact of strokes, with Raychev detailing the "FAST" acronym (Facial asymmetry, Arm weakness, Speech changes, Time to call emergency services) that serves as a reminder for recognizing stroke symptoms. He also discusses their aim to integrate AI algorithms with everyday consumer devices and Emergency Medical Services (EMS) systems to enhance stroke detection and response times.

Key Topics Covered:

• Overview of Neuronics Medical and its mission to improve stroke diagnosis.
• Importance of timely detection in minimizing stroke-related disabilities.
• Statistics illustrating the global impact of strokes, including mortality and disability rates.
• The "FAST" acronym and its significance in recognizing stroke symptoms.
• Technological advancements that utilize AI to detect stroke symptoms through video and audio input.
• Challenges in implementation, including the need for large-scale data validation.
• Potential applications of the technology in consumer devices and automated systems.
• The role of community and investor engagement in scaling Neuronics Medical’s innovations.